Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Daily News Briefs
Aug 2005
Corning Inc. has been granted a license for patent rights to reverse transfection method technology for the drug discovery research market by the Whitehead Institute for Biomedical Research, through Massachusetts Institute of Technology (MIT), its licensing agent. Corning will use the intellectual property with fundamental technology it previously licensed from Aastrom Biosciences Inc. to enhance the development of its molecular and cell culture applications. Corning holds exclusive rights to Aastrom's surface-mediated cell transfection technology, used to increase the frequency and efficiency of introducing foreign genes into cells.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.